Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$379,832.00
Oct 1, 2012
Investigating the Yeast Mitochondrial Interactome for Disease-Gene Discovery
$100,000.00
Oct 1, 2012
Tumor targeted polymeric nanocarriers for oncogene silencing therapy of metastatic breast cancer
$267,472.00
Oct 1, 2012
Characterization of dendritic cells in hepatitis C patients and applications to dendritic cell-based therapy.
$502,747.00
Oct 1, 2012
Genetics of gene expression in the lung to elucidate the molecular causes of asthma and smoking-related lung diseases
$321,980.00
Oct 1, 2012
Integrated Mindfulness-based Cognitive Behaviour Therapy versus Cognitive Behaviour Therapy for Provoked Vestibulodynia
$369,889.00
Oct 1, 2012
Targeted MicroRNA-126 Therapy For Chronic Ischemia
$797,778.00
Oct 1, 2012
Role of poly(A) binding protein in gene expression
$165,000.00
Oct 1, 2012
A randomized controlled trial of bright light therapy on post-treatment fatigue, sleep/wake activity and mood in women with breast cancer.
$685,338.00
Oct 1, 2012
The impact of 3D nuclear chromosome and gene positions on cancer
$768,956.00
Oct 1, 2012
Mechanisms of RNase III-dependent regulation of gene expression